Fox 19 highlights Lung Cancer Awareness Month
November 16, 2022
The University of Cincinnati's Sandra L. Starnes joined Fox 19's morning show to discuss lung cancer screening and treatment options during Lung Cancer Awareness Month.
November 16, 2022
The University of Cincinnati's Sandra L. Starnes joined Fox 19's morning show to discuss lung cancer screening and treatment options during Lung Cancer Awareness Month.
November 15, 2022
The University of Cincinnati's Randall Wickett spoke with Cosmetics Design Asia about the importance of cosmetics industries being able to verify claims about their products and new technology that will allow the industry to do so.
November 15, 2022
The University of Cincinnati's Jeffrey Strawn led research that found in utero exposure to certain flame retardant chemicals may be a risk factor for developing anxiety symptoms in early adolescence.
November 10, 2022
The University of Cincinnati's Shana Feibel spoke with Healthline about the importance of self-esteem.
November 9, 2022
WCPO featured the University of Cincinnati's Rifat Wahab in an article about racial disparities in breast cancer diagnoses and work being done to address the issue.
November 8, 2022
The University of Cincinnati's Stacie Demel, DO, PhD, joined the Simply Medicine podcast to discuss TNK, a new treatment for acute ischemic stroke now available to patients across Greater Cincinnati.
November 7, 2022
MSN India highlighted recent research led by the University of Cincinnati's Trisha Wise-Draper about how immunotherapy and immunosuppression affects COVID-19 severity.
November 3, 2022
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, is co-corresponding author of new research in JAMA Oncology that provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity.
November 3, 2022
The University of Cincinnati's Rhonna Shatz was featured in a U.S. News and World Report article on signs that a patient with dementia may need a higher level of care.
November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.